Cubist Systematic Strategies, LLC Ardelyx, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 448,407 shares of ARDX stock, worth $1.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

448,407

Previous 375,467 19.43%

Holding current value

$1.78 Million

Previous $1.94 Million 13.4%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$4.91 - $6.36 $358,135 - $463,898	72,940 Added 19.43%	448,407 $2.2 Million
Q4 2024 Feb 14, 2025	BUY	$4.49 - $6.85 $1.69 Million - $2.57 Million	375,467 New	375,467 $1.94 Million
Q1 2024 May 15, 2024	BUY	$6.05 - $9.74 $7.7 Million - $12.4 Million	1,273,356 Added 953.84%	1,406,854 $10.3 Million
Q4 2023 Feb 14, 2024	SELL	$3.29 - $6.64 $62,608 - $126,359	-19,030 Reduced 12.48%	133,498 $827,000
Q3 2023 Nov 14, 2023	BUY	$3.3 - $4.83 $503,342 - $736,710	152,528 New	152,528 $622,000
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $688,301 - $1.23 Million	256,829 Added 69.52%	626,281 $3 Million
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $319,385 - $746,104	261,791 Added 243.16%	369,452 $1.05 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $58,275 - $142,231	98,772 Added 1111.17%	107,661 $128,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $116,025 - $266,175	-227,500 Reduced 96.24%	8,889 $5,000
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $237,517 - $431,184	-365,411 Reduced 60.72%	236,389 $253,000
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $517,548 - $1.02 Million	601,800 New	601,800 $662,000
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $341,877 - $468,711	-52,195 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $133,864 - $168,757	21,945 Added 72.55%	52,195 $346,000
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $3,050 - $4,288	-604 Reduced 1.96%	30,250 $196,000
Q3 2020 Nov 16, 2020	BUY	$5.25 - $7.08 $161,983 - $218,446	30,854 New	30,854 $162,000
Q2 2020 Aug 14, 2020	SELL	$5.37 - $8.11 $396,649 - $599,037	-73,864 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.35 - $8.79 $191,500 - $386,962	44,023 Added 147.53%	73,864 $420,000
Q4 2019 Feb 14, 2020	BUY	$4.23 - $8.29 $32,600 - $63,891	7,707 Added 34.82%	29,841 $224,000
Q3 2019 Nov 14, 2019	BUY	$2.15 - $6.28 $47,588 - $139,001	22,134 New	22,134 $104,000
Q3 2018 Nov 14, 2018	SELL	$3.75 - $4.65 $120,997 - $150,036	-32,266 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $75,694 - $118,656	20,458 Added 173.26%	32,266 $119,000
Q1 2018 May 15, 2018	SELL	$5.05 - $7.9 $4,984 - $7,797	-987 Reduced 7.71%	11,808 $60,000
Q4 2017 Feb 14, 2018	BUY	$4.85 - $7.8 $62,055 - $99,801	12,795	12,795 $84,000

Others Institutions Holding ARDX

# of Institutions

235

Shares Held

166M

Call Options Held

490K

Put Options Held

2.35M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $612M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Ardelyx, Inc. Transaction History